Difference between revisions of "Houot R, et al. Ann. Oncol. (2016) cited as Ref 609 in DOI: 10.1038/s41392-020-0110-5 (Q9872)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 27, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Inhibition of Hedgehog signaling for the treatment of lymphoma and CLL: a phase II study from the LYSA, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Inhibition of Hedgehog signaling for the treatment of lymphoma and CLL: a phase II study from the LYSA (English) | ||
| Property / title: Inhibition of Hedgehog signaling for the treatment of lymphoma and CLL: a phase II study from the LYSA (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:05, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Houot R, et al. Ann. Oncol. (2016) cited as Ref 609 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Houot R
0 references
2016
0 references
Ann. Oncol.
0 references
27
0 references
Inhibition of Hedgehog signaling for the treatment of lymphoma and CLL: a phase II study from the LYSA (English)
0 references
